Cargando…

Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy

In patients with various cancers, modified Glasgow prognostic score (mGPS) before treatment has predicted prognoses after antitumor therapy. This study aimed to assess whether pretreatment mGPS also has predictive value in patients with muscle-invasive bladder cancer (MIBC) after radiotherapy. A ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kikuchi, Koyo, Nakamura, Ryuji, Segawa, Takafumi, Oikawa, Hirobumi, Ariga, Hisanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Regular Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336815/ https://www.ncbi.nlm.nih.gov/pubmed/32567660 http://dx.doi.org/10.1093/jrr/rraa039

Ejemplares similares

Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
por: Nakamura, Ryuji, et al.
Publicado: (2020)

Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy
por: Nakamura, Ryuji, et al.
Publicado: (2012)

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma
por: Tian, Rui, et al.
Publicado: (2016)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

External validation of the modified Glasgow prognostic score for renal cancer
por: Tai, Caroline G., et al.
Publicado: (2014)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

Utility of the High-Sensitivity Modified Glasgow Prognostic Scores for Oropharyngeal Carcinoma
por: Iuchi, Hiroyuki, et al.
Publicado: (2021)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience
por: Ferro, Matteo, et al.
Publicado: (2015)

Utility of the Modified and High-Sensitivity Modified Glasgow Prognostic Scores for Hypopharyngeal Squamous Cell Carcinoma
por: Iuchi, Hiroyuki, et al.
Publicado: (2021)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis
por: Fu, Wen, et al.
Publicado: (2020)

A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Zhang, Yongchao, et al.
Publicado: (2022)

Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis
por: Tan, Daqing, et al.
Publicado: (2022)

Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis
por: Jin, Jing, et al.
Publicado: (2017)

The modified Glasgow prognostic score in Crohn’s disease—does it predict short-term outcome?
por: Argeny, Stanislaus, et al.
Publicado: (2018)

Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
por: Xie, Yulian, et al.
Publicado: (2023)

Cardiac impacts of postoperative radiotherapy for breast cancer in Japanese patients
por: Segawa, Erika, et al.
Publicado: (2023)

Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer
por: Iino, Chikara, et al.
Publicado: (2017)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score
por: Draeger, Desiree-Louise, et al.
Publicado: (2023)

Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis
por: Hu, Xu, et al.
Publicado: (2019)

Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients
por: Wu, Dongdong, et al.
Publicado: (2021)

Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion
por: Shiba, Shintaro, et al.
Publicado: (2016)

High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients
por: Choi, Kyeong Woon, et al.
Publicado: (2014)

The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Zhang, Peng, et al.
Publicado: (2014)

Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel
por: Ando, Keisuke, et al.
Publicado: (2021)

Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study
por: Tsai, Yao-Te, et al.
Publicado: (2022)

Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
por: Kasahara, Kenta, et al.
Publicado: (2022)

Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis
por: Yang, Chenli, et al.
Publicado: (2023)

Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy
por: Ferro, Matteo, et al.
Publicado: (2022)

Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0‐III colorectal cancer after curative resection
por: Ishikawa, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o2brmlj0beq4c5ot6gbpfor6f2